List view / Grid view
9 September 2015 | By Victoria White
New research suggests genetic inheritance is much more important in testicular cancer than in most other cancer types, where genetics typically accounts for less than 20% of risk...
18 August 2015 | By Victoria White
Testing for genetic risk factors could improve treatment for myeloma patients by identifying those at risk of developing more aggressive disease...
23 July 2015 | By Victoria White
CCT245737, a new drug that blocks cancer’s escape route from chemotherapy, could be used to treat deadly lung and pancreatic cancers...
2 July 2015 | By Victoria White
Scientists have pioneered the use electron cryo-microscopy (cryo-EM) to picture in exquisite detail one of the central proteins of life...
12 June 2015 | By Victoria White
Scientists have identified that errors in a gene known as TCF12 are associated with more aggressive forms of a disease called anaplastic oligodendroglioma...
28 May 2015 | By Victoria White
Researchers have found genetic evidence that dormant cancer cells can avoid the effects of treatment only to ‘wake up’ many years later...
21 May 2015 | By Victoria White
Almost 90% of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs...
6 May 2015 | By Victoria White
Scientists at The Institute of Cancer Research have found that ROCK inhibitors dramatically reduced the ability of melanoma cells to move through tissue...
21 April 2015 | By Victoria White
Men with prostate cancer benefit from treatment with the pioneering drug olaparib according to the results of a major trial presented today...
1 April 2015 | By Victoria White
A consortium will collaborate with Basilea to progress a new family of cancer drugs designed to block several key cancer-causing proteins at once...
26 March 2015 | By Victoria White
Scientists have revealed a brand new function for one of the first cancer genes ever discovered – the retinoblastoma gene...
23 March 2015 | By Victoria White
A blood test that measures the number of prostate tumour cells shed into the bloodstream can act as an early warning sign that treatment is not working...
19 March 2015 | By Victoria White
PARP inhibitors that target cancers with mutations in the BRCA breast cancer genes could also work against tumours with another type of genetic fault...
4 March 2015 | By The Institute of Cancer Research
Testing breast cancer cells for how closely they resemble stem cells could identify women with the most aggressive disease, a new study suggests...
4 March 2015 | By The Institute of Cancer Research
Changing the shape of breast cancer cells could make the disease more sensitive to treatments – even driving the body’s own inflammatory response against a tumour – a new study shows...
